Frankfurt - Delayed Quote EUR

Beijing Tong Ren Tang Chinese Medicine Company Limited (TQR.F)

1.1200 +0.0200 (+1.82%)
At close: April 26 at 8:00 AM GMT+2
Currency in HKD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,524,945.0000
1,524,945.0000
1,731,095.0000
1,556,158.0000
1,315,346.0000
Cost of Revenue
477,702.0000
477,702.0000
580,955.0000
436,535.0000
362,443.0000
Gross Profit
1,047,243.0000
1,047,243.0000
1,150,140.0000
1,119,623.0000
952,903.0000
Operating Expense
408,439.0000
408,439.0000
334,851.0000
336,577.0000
282,078.0000
Operating Income
638,804.0000
638,804.0000
815,289.0000
783,046.0000
670,825.0000
Net Non Operating Interest Income Expense
66,900.0000
66,900.0000
15,927.0000
-330.0000
17,352.0000
Pretax Income
687,790.0000
687,790.0000
825,962.0000
778,391.0000
685,895.0000
Tax Provision
97,203.0000
97,203.0000
134,669.0000
126,848.0000
118,014.0000
Net Income Common Stockholders
540,393.0000
540,393.0000
645,875.0000
607,838.0000
542,456.0000
Diluted NI Available to Com Stockholders
540,393.0000
540,393.0000
645,875.0000
607,838.0000
542,456.0000
Basic EPS
0.65
--
0.77
0.73
0.65
Diluted EPS
0.65
--
0.77
0.73
0.65
Basic Average Shares
837,100.0000
--
837,100.0000
837,100.0000
837,100.0000
Diluted Average Shares
837,100.0000
--
837,100.0000
837,100.0000
837,100.0000
Total Operating Income as Reported
624,149.0000
624,149.0000
811,575.0000
778,460.0000
669,403.0000
Rent Expense Supplemental
13,811.0000
--
--
--
--
Total Expenses
886,141.0000
886,141.0000
915,806.0000
773,112.0000
644,521.0000
Net Income from Continuing & Discontinued Operation
540,393.0000
540,393.0000
645,875.0000
607,838.0000
542,456.0000
Normalized Income
556,117.8540
556,117.8540
651,082.8140
613,106.9150
545,210.5617
Interest Income
72,878.0000
72,878.0000
20,588.0000
4,377.0000
21,652.0000
Interest Expense
5,978.0000
5,978.0000
4,661.0000
4,707.0000
4,300.0000
Net Interest Income
66,900.0000
66,900.0000
15,927.0000
-330.0000
17,352.0000
EBIT
693,768.0000
693,768.0000
830,623.0000
783,098.0000
690,195.0000
EBITDA
776,282.0000
776,282.0000
906,093.0000
853,070.0000
768,281.0000
Reconciled Cost of Revenue
477,702.0000
477,702.0000
580,955.0000
436,535.0000
362,443.0000
Reconciled Depreciation
82,514.0000
82,514.0000
75,470.0000
69,972.0000
78,086.0000
Net Income from Continuing Operation Net Minority Interest
540,393.0000
540,393.0000
645,875.0000
607,838.0000
542,456.0000
Total Unusual Items Excluding Goodwill
-18,306.0000
-18,306.0000
-6,222.0000
-6,295.0000
-3,327.0000
Total Unusual Items
-18,306.0000
-18,306.0000
-6,222.0000
-6,295.0000
-3,327.0000
Normalized EBITDA
794,588.0000
794,588.0000
912,315.0000
859,365.0000
771,608.0000
Tax Rate for Calcs
0.0001
0.0001
0.0002
0.0002
0.0002
Tax Effect of Unusual Items
-2,581.1460
-2,581.1460
-1,014.1860
-1,026.0850
-572.4383
12/31/2020 - 12/16/2013

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade